提奥根的配方通过激活AMPK-PPARγ-LXRα通路来减轻动脉样硬化
Yue Zhang1, Miao Zeng1, Xiaolu Zhang1
1School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Journal of ethnopharmacology
|January 29, 2024
概括
提阿冈·道祖配方 (TGDZF) 通过增强巨细胞的胆固醇外流来有效治疗动脉样硬化. 这种传统配方激活AMPK-PPARγ-LXRα-ABCA1通路,减少斑块形成和改善脂质配置.
科学领域:
- 药理学和中国传统医学
- 心血管研究研究心血管研究
- 分子生物学分子生物学
背景情况:
- 动脉样硬化是一种重要的心血管疾病,治疗选择有限.
- 提阿冈达州配方 (TGDZF) 是一种用于治疗动脉样硬化的传统中医药,但其作用机制尚未完全理解.
研究的目的:
- 在动脉样硬化小鼠模型中研究TGDZF的治疗疗效.
- 阐明TGDZF抗动脉样硬化作用背后的分子机制.
主要方法:
- 动脉样硬化被诱导在ApoE-/-小鼠食高脂肪饮食和治疗TGDZF.
- 使用超声波,组织学和脂质水平测量来评估有效性.
- 分析了胆固醇外流,巨细胞泡细胞的形成,以及关键蛋白质 (AMPKα1,PPARγ,LXRα,ABCA1) 的表达.
主要成果:
- TGDZF治疗减少了大动脉斑块面积,脂质积累,并改善了血清脂质概况.
- TGDZF增加了胆固醇外流,并上调了PPARγ,LXRα和ABCA1的表达.
- 抑制AMPK或PPARγ部分扭转了TGDZF的有益作用.
结论:
- TGDZF在缓解动脉样硬化方面表现出显著的有效性.
- TGDZF通过AMPK-PPARγ-LXRα-ABCA1信号通路促进巨细胞中的胆固醇流出.
更多相关视频
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
2.0K
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
418
相关概念视频
cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
Inflammation
53.4K
Overview
53.4K
GPCRs Regulate Adenylyl Cylase Activity
5.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
